Infectious Coryza in Poultry: Diagnosis, Symptoms, and Causal Pathogen

Introduction

Infectious coryza is an acute respiratory disease of poultry primarily caused by Avibacterium paragallinarum (formerly Haemophilus paragallinarum). The disease is characterized by catarrhal inflammation of the upper respiratory tract, including the nasal passages, sinuses, and conjunctiva. Infectious coryza is of significant economic concern in commercial layer and broiler breeder flocks because it reduces egg production, increases culling rates, and predisposes birds to secondary bacterial infections. This article provides a detailed examination of the causal pathogen, clinical signs, diagnostic approaches, and treatment strategies relevant to veterinary practice and flock health management.

Causal Pathogen: Avibacterium paragallinarum

Taxonomy and Morphology

Avibacterium paragallinarum is a Gram-negative, nonmotile, pleomorphic rod or coccobacillus belonging to the family Pasteurellaceae. The bacterium is facultatively anaerobic and requires nicotinamide adenine dinucleotide (NAD, also known as V factor) for growth, a characteristic shared with other members of the genus Avibacterium. On solid media, colonies are small, dewdrop-like, and nonhemolytic after 24 to 48 hours of incubation at 37 degrees Celsius in a carbon dioxide enriched atmosphere. Satellite growth is observed adjacent to feeder streaks of Staphylococcus epidermidis or other NAD producing organisms.

Antigenic Structure and Serotyping

The organism possesses capsular polysaccharides and lipopolysaccharides that define its serovar specificity. Historically, three serovars (A, B, and C) were identified by Page using agglutination tests. A modified scheme by Kume and colleagues expanded the classification into serogroups I, II, and III with further subtypes. The Page scheme remains widely used in diagnostic laboratories. Cross protection between serovars is limited, and effective vaccination requires multivalent bacterins containing local field serovars.

Pathogenesis and Virulence Factors

Avibacterium paragallinarum colonizes the upper respiratory mucosa after inhalation of contaminated aerosols or dust. The bacterium adheres to ciliated epithelial cells via fimbriae and other adhesins. A polysaccharide capsule inhibits phagocytosis. The organism produces neuraminidase and a heat labile toxin that contribute to mucosal damage and inflammation. Infection typically remains localized to the nasal cavity and sinuses, but systemic dissemination can occur in immunocompromised birds or under stress. Incubation period ranges from 1 to 3 days after natural exposure.

Clinical Signs

The clinical presentation of infectious coryza is influenced by bird age, immune status, environmental stress, and concurrent infections. Classical signs include:

• Serous to mucopurulent nasal discharge that matures from clear to thick yellow.
• Facial edema, especially involving the infraorbital sinuses and periorbital region.
• Conjunctivitis with frothy ocular discharge.
• Swollen wattles in males.
• Head shaking and sneezing.
• Dyspnea in severe cases due to nasal obstruction.
• Anorexia, depression, and reduced water consumption.
• Drop in egg production in layers (typically 10 to 40 percent).
• Increased culling due to blindness or dehydration.

In young birds, morbidity can reach 100 percent while mortality is usually low (below 5 percent) unless secondary infections with Escherichia coli, Mycoplasma gallisepticum, or Ornithobacterium rhinotracheale occur. Chronic carrier states are common after recovery, and recovered birds can shed the organism intermittently.

Diagnosis

Accurate diagnosis is essential for implementing appropriate control measures and differentiating infectious coryza from other respiratory diseases. The diagnostic workflow integrates clinical observation, bacteriological culture, molecular assays, and serological testing.

Clinical and Necropsy Findings

Suspicion is raised by the characteristic facial swelling and nasal discharge in a flock. At necropsy, the nasal passages and infraorbital sinuses contain copious mucoid to purulent exudate. The mucosa appears hyperemic and edematous. Pneumonia is not a primary feature unless secondary invaders are present.

Bacteriological Isolation and Identification

Swabs from the nasal cavity, infraorbital sinuses, or choanal cleft are collected and placed in transport medium (e.g., Amies with charcoal). Samples are streaked onto chocolate agar supplemented with NAD and incubated at 37 degrees Celsius in 5 percent carbon dioxide. Typical growth appears as small, grayish, translucent colonies after 24 hours. Identification is confirmed by Gram stain (Gram-negative pleomorphic rods), satellite dependence on NAD, and negative catalase reaction. Avibacterium paragallinarum is oxidase positive and reduces nitrates. Biochemical differentiation from Pasteurella multocida (causative agent of fowl cholera) and Gallibacterium species is critical.

Molecular Diagnostics

Polymerase chain reaction (PCR) assays targeting the Avibacterium paragallinarum specific gene (e.g., HMTp05 or 16S rRNA) provide rapid and sensitive detection directly from clinical specimens. Real-time PCR formats are available for quantification and serotyping. Molecular methods are particularly useful for detecting carriers and for confirming diagnosis when bacterial culture is negative due to prior antibiotic treatment or poor sample quality.

A diagnostic decision tree is presented below.

flowchart TD
    A[Flock with respiratory signs: nasal discharge, facial swelling, conjuncitivitis], > B{Clinical assessment}
    B, > C[Collect nasal or sinus swabs]
    C, > D[Conduct PCR for A. paragallinarum]
    D, > E[PCR positive?]
    E, Yes, > F[Confirmed case: initiate treatment and biosecurity]
    E, No, > G[Plate on chocolate agar + NAD; incubate 37C, 5% CO2]
    G, > H[Satellite growth?]
    H, Yes, > I[Gram stain, biochemical tests]
    H, No, > J[Consider differential diagnoses]
    I, > K[Identify A. paragallinarum]
    K, > L[Serotyping by agglutination or multiplex PCR]
    L, > M[Choose appropriate vaccine serovars]
    J, > N[Test for Mycoplasma, Avian Influenza, Pasteurella, etc.]

Serological Testing

Serological methods include hemagglutination inhibition and enzyme-linked immunosorbent assays (ELISA). Commercial ELISA kits are available for detecting antibodies against Avibacterium paragallinarum. Serology is used primarily for monitoring vaccine response and flock seroprevalence, not for acute diagnosis. For information on ELISA principles in a viral context, see the article on Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus.

Differential Diagnosis

The table below lists key differential diagnoses for infectious coryza in poultry.

Serotyping Methods

Determination of serovar is important for vaccine selection and epidemiological studies. Traditional serotyping uses the Page scheme with agglutination tests using hyperimmune rabbit antisera against serovars A, B, and C. Kume serotyping uses hemagglutination inhibition. More recently, multiplex PCR assays targeting serovar specific genes (e.g., hagA for serovar A, hagB for serovar C) enable molecular serotyping within hours. Serovar B strains are antigenically heterogeneous and may not be detected by some molecular panels.

Treatment and Control

Antimicrobial Therapy

The disease responds to antibiotic treatment, but complete elimination of the organism from a flock is difficult. Commonly used antimicrobials include sulfonamides, tetracyclines, tylosin, and erythromycin. Antibiotic sensitivity testing from culture isolates is recommended due to variable resistance patterns. Treatment is most effective when initiated early and administered in water or feed for 5 to 7 days. Chronic carrier birds may relapse after treatment cessation.

Vaccination

Bacterins (killed vaccines) containing multiple serovars are administered to pullets before placement in layer houses. Autogenous vaccines prepared from the farm specific isolate can improve protection. Vaccination reduces clinical signs and shedding but does not prevent infection entirely. A combined program of vaccination and biosecurity is the most effective control strategy.

Biosecurity and Management

Infectious coryza is transmitted horizontally through direct contact, aerosol, and contaminated equipment. Recovered birds remain carriers. Control measures include:

• All in-all out flock management.
• Quarantine of new introductions.
• Cleaning and disinfection of houses between flocks.
• Avoidance of shared equipment between different age groups.
• Minimizing stress factors such as overcrowding, poor ventilation, and nutritional deficiencies.

Because the disease can be confused with other respiratory conditions, confirmatory diagnostic testing is essential before committing to a treatment and control program. For further reference on respiratory diseases in poultry, see the articles on Infectious Coryza in Chickens and Quail and Fowl Cholera in Poultry.

Conclusion

Infectious coryza remains a prevalent respiratory disease in intensively managed poultry flocks worldwide. Avibacterium paragallinarum is a fastidious Gram-negative bacterium requiring NAD for growth. Clinical signs include nasal discharge, facial swelling, and conjunctivitis with associated production losses. Diagnosis relies on bacterial culture, PCR, and serological methods. Serotyping guides vaccine selection. Treatment with appropriate antibiotics and implementation of vaccination and biosecurity protocols are necessary for effective control. Differentiation from other respiratory agents such as avian influenza virus, Pasteurella multocida, and Mycoplasma gallisepticum is critical for appropriate management.

References

1. Blackall PJ, Christensen H, Beckenham T, Bisgaard M. Reclassification of Haemophilus paragallinarum as Avibacterium paragallinarum gen. nov., comb. nov. International Journal of Systematic and Evolutionary Microbiology. 2005;55(1):353-356.
2. Blackall PJ, Soriano VE. Infectious coryza and related diseases. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Wiley Blackwell; 2020. p. 890-906.
3. World Organisation for Animal Health (WOAH). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.3.4: Infectious coryza. WOAH; 2021.